Crucial kit runs out for allergy kids

Children with severe allergies face difficulties with treatment as a popular medicine has been declared “out of stock” amid a continuing shortage.

Epipen and Epipen Junior devices, supplied by Mylan and produced by Pfizer, have faced shortages in the UK and other countries for months, but the Junior version is now unavailable.

A statement issued to healthcare providers on behalf of the Department of Health noted: “Epipen and Epipen Junior will be subject to limited availability for the remainder of 2018. “Mylan are now out of stock of Epipen Junior, and interruptions in the supply are anticipated to continue for the coming months.”

More of the Junior devices are expected in stock in October, but it is not clear whether these will meet demand.

Epipens are the most common adrenaline auto-injector (AAI) devices and are issued to people who suffer from serious allergies.

People are recommended to keep two AAIS with them at all times in case of reaction.

The standard device contains 300mcg of adrenaline.

Smaller 150mcg “Junior” AAIS are issued to children who weigh 4st 10lb or less.

Meanwhile, adults and older children are being advised they can use their devices up to four months beyond the listed expiry date in an attempt to maintain supply levels.

The extension does not apply to any Epipen Junior devices.